RSAD2 and cancer: To investigate whether viperin as a driver of cancer metabolic reprogramming is induced in the TME, we measured its expression levels under IFN-γ treatment, serum starvation, or hypoxia in various cancer cell lines (Figure 3A and Supplemental Figure 5A).